Programmable Control Services Inc. was founded in 1983 and full time operations were originally out of Palatine,
Illinois. In 1987, the company was incorporated as a Washington State
corporation and moved to Spokane. From the outset, Programmable Control Services
(PCS) provided a broad range of integration services to various industry sectors
that required programmable control infrastructure. In 1995, operations focused
essentially on the electric utility business and began serving a wide range of
satisfied customers, which which PCS has maintained solid ties
throughout the years. PCS moved to its current facilities on Market Street in
Spokane, in 1997. This allowed the consolidation of its panel assembly shop and
engineering offices.
At the turn of the new millennium,
PCS embarked on an extensive R&D effort aimed at developing Automated Energy
Management Systems for the electric distribution utilities market. Due to its
stalwart market presence and leadership as a system integrator, the company
maintained the high standards that founded the business nearly two decades ago
and continues to serve the electric utilities market in the US and Canada. In
2001, PCS changed its name to PCS UtiliData to more accurately reflect its focus
on the electric utility industry. That same year, PCS UtiliData was awarded the
CSIA’s first annual ‘Remember Me’ Memorial Award for leadership in the control
system integrator industry.
In 2002, the R&D program undertaken
a few years prior paid off. This product development thrust led to the launch by
PCS UtiliData of a unique product aimed at the electricity distribution sector.
This product, AdaptiVolt™, offers utilities the ability to dynamically adjust
the voltage at the electrical substation to achieve the desired energy
consumption target while staying within regulatory compliance and yielding
significant energy savings.
In 2005, PCS UtiliData continues to
serve utility and industrial customers across the nation with the excellence and
expertise that our clients have become accustomed to.